<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://repository.usmf.md:80/handle/20.500.12710/531">
    <title>DSpace Community: Moldovan Journal of Health Sciences</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/531</link>
    <description>Moldovan Journal of Health Sciences</description>
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/33679" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/33662" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/33661" />
        <rdf:li rdf:resource="http://repository.usmf.md:80/handle/20.500.12710/33657" />
      </rdf:Seq>
    </items>
    <dc:date>2026-09-23T16:24:39Z</dc:date>
  </channel>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/33679">
    <title>Predictors of community-acquired pneumonia severity in patients with chronic heart failure</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/33679</link>
    <description>Title: Predictors of community-acquired pneumonia severity in patients with chronic heart failure
Authors: Cașcaval, Virginia; Dumitraș, Tatiana; Fetco-Mereuță, Diana; Grib, Livi; Matcovschi, Sergiu; Talmaci, Cornelia; Caproș, Natalia; Bivol, Elena
Abstract: Introduction. Community-acquired pneumonia (CAP) remains a major cause of morbidity and mortality, particularly in&#xD;
patients with chronic heart failure (CHF), who are at increased risk of adverse outcomes. Identifying reliable predictors&#xD;
of disease severity in this population is essential for timely risk stratification and optimization of therapeutic strategies.&#xD;
Aim of the study. Assessment of clinical and disease-course characteristics, oxidative stress, and predictors of CAP severity&#xD;
in patients with CHF.&#xD;
Materials and methods. A total of 210 patients were enrolled in the study and divided into two groups: group 1 (n =&#xD;
105) – patients with community-acquired pneumonia associated with chronic heart failure and group 2 (n = 105) – patients&#xD;
with community-acquired pneumonia without chronic heart failure. The research was conducted based on clinical&#xD;
examination of patients, daily monitoring of the inflammatory process, assessment of comorbidities, and paraclinical investigations.&#xD;
Statistical analysis of the collected data was performed using a wide range of methods, including descriptive&#xD;
statistics, correlational analysis, and regression models.&#xD;
Results. The age of patients in the study group ranged from 50 to 92 years, with a mean of 70.6 ± 8.89 years (95% CI&#xD;
[68.8–72.3]), (F = 18.109; p = 0.205). In Group 1, the proportion of women was 57 (54.3%; 95% CI [44.8-64.1]), and that&#xD;
of men was 48 (45.7%; 95% CI [35.9-55.2]). In Group 2, the proportion of men was higher than that of women: 54 (51.4%;&#xD;
95% CI [42.3-61.0]) men and 51 (48.6%; 95% CI [39.0-57.7]) women, respectively (χ2 = 0.686; df = 1; p = 0.407). Ischemia-&#xD;
modified albumin values were higher in patients in Group 1 compared to Group 2: 236.60 ± 57.23 μM/L and 229.77 ±&#xD;
64.35 μM/L, respectively, (F = 0.660; p = 0.045). The IMA threshold value of 218.98 μM/L was determined for patients with&#xD;
CHF and severe CAP. The mean NT-proBNP values in Group 1 patients were 1371.88 ± 498.91 pg/ml, compared to Group 2:&#xD;
58.19 ± 48.22 pg/ml, (F = 721.54; p &lt; 0.0001). The NT-proBNP threshold value of 1665.73 pg/ml was identified for severe&#xD;
CAP in CHF patients. A method which allows early detection in 87.0% of cases of patients with CHF at high risk of severe&#xD;
community-acquired pneumonia was developed.&#xD;
Conclusions. Our hypothesis that community-acquired pneumonia in patients with chronic heart failure is more frequently&#xD;
associated with a severe clinical course was confirmed. The proposed NT-proBNP and ischemia-modified albumin threshold&#xD;
values, together with our risk estimation formula, may improve early therapeutic intervention to prevent severe complications.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/33662">
    <title>Non-immune fetal hydrops and intestinal obstruction: rare manifestations of congenital syphilis</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/33662</link>
    <description>Title: Non-immune fetal hydrops and intestinal obstruction: rare manifestations of congenital syphilis
Authors: Neagu, Anastasia; Crivceanscaia, Larisa
Abstract: Introduction. Fetal hydrops is defined as the pathological accumulation of extracellular fluid in at least two fetal anatomical compartments, including skin edema (&gt; 5 mm thickness), pericardial effusion, pleural effusion, and ascites. Non-immune fetal hydrops (NIHF) accounts for over 90% of all fetal hydrops cases and has a heterogeneous etiology. Congenital&#xD;
infections contribute to approximately 6–7% of NIHF cases and are associated with a severe neonatal prognosis.&#xD;
Case presentation. A preterm newborn was delivered from a pregnancy complicated by untreated maternal primary&#xD;
syphilis. The fetus had been diagnosed antenatally with NIHF, heart failure, and massive ascites. Postnatally, the infant&#xD;
required early ascitic drainage and subsequently underwent surgery for congenital intestinal obstruction in the context&#xD;
of ileal stenosis. Neonatal serological testing revealed a positive rapid plasma reagin (RPR) and a reactive Treponema pallidum Hemagglutination Assay (TPHA). Management of congenital syphilis was carried out according to the standardized&#xD;
national clinical protocol. The collected data were compared with those reported in the existing literature to assess clinical&#xD;
significance.&#xD;
Results. The neonate showed a favorable clinical evolution following multidisciplinary management, including intensive&#xD;
care support, anti-infective therapy, and surgical correction of the intestinal obstruction. Progressive improvement allowed successful postoperative recovery and discharge in satisfactory condition.&#xD;
Conclusions. Early identification of the infectious etiology of fetal hydrops is essential for the implementation of appropriate management and the improvement of neonatal outcomes. Close collaboration between maternal–fetal medicine,&#xD;
neonatology, and pediatric surgery is crucial in managing such complex cases.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/33661">
    <title>Healthcare-associated bloodstream infections in children: epidemiology, risk factors and prevention strategies</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/33661</link>
    <description>Title: Healthcare-associated bloodstream infections in children: epidemiology, risk factors and prevention strategies
Authors: Marga, Irina
Abstract: Introduction. Health care-associated bloodstream infections represent a major public health concern, significantly impacting morbidity, mortality, and the overall cost of pediatric medical care.&#xD;
Materials and methods. A literature review was conducted based on systematic searches in PubMed, SCOPUS, and Web&#xD;
of Science, following PRISMA guidelines.&#xD;
Results. The incidence of healthcare-associated bloodstream infections ranges from 2 to 25 cases per 1,000 central venous&#xD;
catheter days, with higher rates reported in pediatric and neonatal intensive care units, where patients are frequently&#xD;
exposed to risk factors such as central venous catheter use, mechanical ventilation, and immunosuppression. Pediatric&#xD;
patients with health care-associated bloodstream infections experience significantly longer hospital stays compared to&#xD;
those without infection (25 vs. 7 days, P &lt; 0.0001). In pediatric intensive care units, the average length of hospital stay due&#xD;
to these infections varies between 11.40 and 21.10 days, while in neonatal intensive care units, it ranges from 4 to 27.80&#xD;
days. Mortality associated with these infections among children varies between 15% and 50%, depending on the severity&#xD;
of infection and underlying comorbidities. Additionally, health care-associated bloodstream infections lead to increased&#xD;
use of medical resources and generate substantial additional costs for the healthcare system-costs that are, in fact, largely&#xD;
preventable.&#xD;
Conclusions. Evidence-based strategies, such as strict hand hygiene and standardized protocols for medical device use,&#xD;
can significantly reduce the incidence of these infections.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
  <item rdf:about="http://repository.usmf.md:80/handle/20.500.12710/33657">
    <title>Tick-borne mix infection diagnosis, challenges, and current practices</title>
    <link>http://repository.usmf.md:80/handle/20.500.12710/33657</link>
    <description>Title: Tick-borne mix infection diagnosis, challenges, and current practices
Authors: Sofronie, Olga; Bălan, Greta
Abstract: Introduction. Tick-borne infections (TBIs) are increasingly recognized as a public health concern in North America and&#xD;
Europe, with Lyme disease being the most notable. The Centers for Disease Control and Prevention (CDC) acknowledges&#xD;
that official statistics likely underestimate the true incidence of TBIs due to diagnostic challenges and underreporting.&#xD;
Co-infections, where multiple pathogens are transmitted through a single tick bite or multiple bites, complicate diagnosis&#xD;
and treatment, leading to more severe symptoms and longer illness durations. Studies indicate a significant percentage of&#xD;
Lyme disease patients also have co-infections, with babesiosis being a common co-infection.&#xD;
Materials and methods. A comprehensive narrative literature review was conducted using PubMed and Scopus, resulting&#xD;
in 52 manuscripts. Additional reports from the CDC and European Centre for Disease Prevention and Control (ECDC), as&#xD;
well as relevant academic books, were included to meet the study’s objectives. The Elicit platform was utilized to enhance&#xD;
reference identification and information synthesis.&#xD;
Results. The paper provides an overview of tick-borne co-infections, emphasizing the diagnostic challenges posed by overlapping and nonspecific symptoms. It discusses various diseases, including Lyme disease, babesiosis, anaplasmosis, ehrlichiosis, Rocky Mountain spotted fever, and tick-borne encephalitis, detailing their causative organisms, vectors, clinical&#xD;
features, and common co-infections. The review critically examines diagnostic methods such as serological tests, molecular&#xD;
tests, and blood smears, highlighting issues like the „window period” false negatives/positives, and differentiating active&#xD;
from past infections. It also explores emerging technologies and biomarkers, including multiplex assays and next-generation sequencing, which enhance detection capabilities but face challenges in data analysis and standardization.&#xD;
Conclusions. Accurate diagnosis is crucial to manage these infections effectively, particularly in vulnerable populations.&#xD;
The rise in co-infections and inadequate testing presents a significant public health challenge, necessitating improved surveillance and diagnostic approaches.</description>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

